Why is Core Scientific stock up today?

Traders Union
All News
Financial News
Core scientific surges 5.39% today

Highlights

Core Scientific trades in a strong uptrend above major moving averages, with bullish momentum confirmed across daily and weekly timeframes.
Overbought signals from multiple oscillators suggest risk of short-term consolidation or pullback despite prevailing buyer dominance.
Expected five-session range is $25.62 to $29.27, with 75% probability of further upside unless $25.62 support fails.

Anton Kharitonov, expert at Traders Union, notes that Core Scientific’s recent 5.39% rally keeps it above major moving averages, but remains wary of the underlying sustainability. He observes that technical momentum is robust, but oscillators flag overbought conditions, raising concerns about a near-term pullback. The absence of supportive news flow adds to the uncertainty from a sentiment and fundamental perspective. Technical momentum could quickly reverse if profit-taking accelerates below $25.62 support. "Aggressive traders should manage risk tightly — overbought signals and lack of news could trigger a sharp correction."

Viktoras Karapetjanc, expert at Traders Union, sees Core Scientific maintaining a clearly bullish structure while price action consistently holds above key averages. He points out that positive weekly technical signals and a dominant bull presence increase the odds of further gains. Karapetjanc is encouraged by the stock’s strong momentum and anticipates higher volatility favoring buyers. He acknowledges a lack of recent news but views it as leaving room for upcoming catalysts. "I expect buyer conviction to remain high — a break above $29.27 could open up new opportunities for growth."

Parshwa Turakhiya, analyst, highlights the strong trading session and intraday dominance by buyers as key sentiment drivers. He notes the mix of bullish momentum and overbought technical readings suggests the trend can persist, but quick reversals are possible. With volatility elevated, Turakhiya prefers short-term setups that capture swift directional moves. "Given the oscillators and upper-range price action, I see tactical opportunities on both sides for agile traders."

Overbought signals emerge as strong momentum drives price near resistance

Core Scientific is trading above its 20-day, 50-day, and 200-day moving averages ($26.06, $22.28, and $18.29 respectively), signaling bullish momentum across all timeframes. The nearest dynamic support is at the Ichimoku Kijun level of $25.64, with medium-term resistance likely around the 50-day average or the $28.00 round level. Momentum remains strong with the MACD giving a strong buy signal, while the Average Directional Index (ADX) confirms positive trend strength on the daily chart. The Relative Strength Index (RSI) is moderately bullish at 52.33, and the Commodity Channel Index (CCI) is neutral, but both the Stochastic RSI and Bull/Bear Power (BBP) indicate overbought conditions; BBP at 0.88 shows that buyers continue to dominate intraday momentum. The Awesome Oscillator also supports this positive tone. Today, the stock has jumped $1.39 or 5.39% to $27.08, opening on a modest upside gap and trading near session highs; intraday volatility stands at 5.67%, reflecting pronounced strength toward the upper end of the range. Several oscillators point to overbought conditions, showing some divergence from persistent daily and weekly momentum.

Earlier, analysts noted that Core Scientific was showing tentative signs of renewed bullish momentum, with traders monitoring for an upside breakout. The stock's breakout above prior resistance and alignment of multiple bullish signals now increase the focus on sustaining momentum above $29.27, where a decisive move could open the door to further gains.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.